Cargando…
An appraisal of allergic disorders in India and an urgent call for action
India is the second most populous country in the world with a population of nearly 1.3 billion, comprising 20% of the global population. There are an estimated 37.5 million cases of asthma in India, and recent studies have reported a rise in prevalence of allergic rhinitis and asthma. Overall, 40–50...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398972/ https://www.ncbi.nlm.nih.gov/pubmed/32774662 http://dx.doi.org/10.1016/j.waojou.2020.100446 |
_version_ | 1783566054267551744 |
---|---|
author | Krishna, Mamidipudi Thirumala Mahesh, Padukudru Anand Vedanthan, Pudupakkam Moitra, Saibal Mehta, Vinay Christopher, Devasahayam Jesudas |
author_facet | Krishna, Mamidipudi Thirumala Mahesh, Padukudru Anand Vedanthan, Pudupakkam Moitra, Saibal Mehta, Vinay Christopher, Devasahayam Jesudas |
author_sort | Krishna, Mamidipudi Thirumala |
collection | PubMed |
description | India is the second most populous country in the world with a population of nearly 1.3 billion, comprising 20% of the global population. There are an estimated 37.5 million cases of asthma in India, and recent studies have reported a rise in prevalence of allergic rhinitis and asthma. Overall, 40–50% of paediatric asthma cases in India are uncontrolled or severe. Treatment of allergic rhinitis and asthma is sub-optimal in a significant proportion of cases due to multiple factors relating to unaffordability to buy medications, low national gross domestic product, religious beliefs, myths and stigma regarding chronic ailment, illiteracy, lack of allergy specialists, and lack of access to allergen-specific immunotherapy for allergic rhinitis and biologics for severe asthma. High quality allergen extracts for skin tests and adrenaline auto-injectors are currently not available in India. Higher postgraduate specialist training programmes in Allergy and Immunology are also not available. Another major challenge for the vast majority of the Indian population is an unacceptably high level of exposure to particulate matter (PM)(2.5) generated from traffic pollution and use of fossil fuel and biomass fuel and burning of incense sticks and mosquito coils. This review provides an overview of the burden of allergic disorders in India. It appraises current evidence and justifies an urgent need for a strategic multipronged approach to enhance quality of care for allergic disorders. This may include creating an infrastructure for education and training of healthcare professionals and patients and involving regulatory authorities for making essential treatments accessible at subsidised prices. It calls for research into better phenotypic characterisation of allergic disorders, as evidence generated from high income western countries are not directly applicable to India, due to important confounders such as ethnicity, air pollution, high rates of parasitic infestation, and other infections. |
format | Online Article Text |
id | pubmed-7398972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | World Allergy Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-73989722020-08-06 An appraisal of allergic disorders in India and an urgent call for action Krishna, Mamidipudi Thirumala Mahesh, Padukudru Anand Vedanthan, Pudupakkam Moitra, Saibal Mehta, Vinay Christopher, Devasahayam Jesudas World Allergy Organ J Article India is the second most populous country in the world with a population of nearly 1.3 billion, comprising 20% of the global population. There are an estimated 37.5 million cases of asthma in India, and recent studies have reported a rise in prevalence of allergic rhinitis and asthma. Overall, 40–50% of paediatric asthma cases in India are uncontrolled or severe. Treatment of allergic rhinitis and asthma is sub-optimal in a significant proportion of cases due to multiple factors relating to unaffordability to buy medications, low national gross domestic product, religious beliefs, myths and stigma regarding chronic ailment, illiteracy, lack of allergy specialists, and lack of access to allergen-specific immunotherapy for allergic rhinitis and biologics for severe asthma. High quality allergen extracts for skin tests and adrenaline auto-injectors are currently not available in India. Higher postgraduate specialist training programmes in Allergy and Immunology are also not available. Another major challenge for the vast majority of the Indian population is an unacceptably high level of exposure to particulate matter (PM)(2.5) generated from traffic pollution and use of fossil fuel and biomass fuel and burning of incense sticks and mosquito coils. This review provides an overview of the burden of allergic disorders in India. It appraises current evidence and justifies an urgent need for a strategic multipronged approach to enhance quality of care for allergic disorders. This may include creating an infrastructure for education and training of healthcare professionals and patients and involving regulatory authorities for making essential treatments accessible at subsidised prices. It calls for research into better phenotypic characterisation of allergic disorders, as evidence generated from high income western countries are not directly applicable to India, due to important confounders such as ethnicity, air pollution, high rates of parasitic infestation, and other infections. World Allergy Organization 2020-08-01 /pmc/articles/PMC7398972/ /pubmed/32774662 http://dx.doi.org/10.1016/j.waojou.2020.100446 Text en © 2020 Published by Elsevier Inc. on behalf of World Allergy Organization. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Krishna, Mamidipudi Thirumala Mahesh, Padukudru Anand Vedanthan, Pudupakkam Moitra, Saibal Mehta, Vinay Christopher, Devasahayam Jesudas An appraisal of allergic disorders in India and an urgent call for action |
title | An appraisal of allergic disorders in India and an urgent call for action |
title_full | An appraisal of allergic disorders in India and an urgent call for action |
title_fullStr | An appraisal of allergic disorders in India and an urgent call for action |
title_full_unstemmed | An appraisal of allergic disorders in India and an urgent call for action |
title_short | An appraisal of allergic disorders in India and an urgent call for action |
title_sort | appraisal of allergic disorders in india and an urgent call for action |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398972/ https://www.ncbi.nlm.nih.gov/pubmed/32774662 http://dx.doi.org/10.1016/j.waojou.2020.100446 |
work_keys_str_mv | AT krishnamamidipudithirumala anappraisalofallergicdisordersinindiaandanurgentcallforaction AT maheshpadukudruanand anappraisalofallergicdisordersinindiaandanurgentcallforaction AT vedanthanpudupakkam anappraisalofallergicdisordersinindiaandanurgentcallforaction AT moitrasaibal anappraisalofallergicdisordersinindiaandanurgentcallforaction AT mehtavinay anappraisalofallergicdisordersinindiaandanurgentcallforaction AT christopherdevasahayamjesudas anappraisalofallergicdisordersinindiaandanurgentcallforaction AT krishnamamidipudithirumala appraisalofallergicdisordersinindiaandanurgentcallforaction AT maheshpadukudruanand appraisalofallergicdisordersinindiaandanurgentcallforaction AT vedanthanpudupakkam appraisalofallergicdisordersinindiaandanurgentcallforaction AT moitrasaibal appraisalofallergicdisordersinindiaandanurgentcallforaction AT mehtavinay appraisalofallergicdisordersinindiaandanurgentcallforaction AT christopherdevasahayamjesudas appraisalofallergicdisordersinindiaandanurgentcallforaction |